In Focus
China to heighten competition for pharma exports to SSA
China to heighten competition for pharma exports to SSA
Nonetheless, India is still expected to be the region’s top supplier.
Chinese biopharmas eye collaboration with western firms
This could help them in promoting indigenous medicines.
China implements pharma patent reforms
It has introduced a patent term extension for drugs.
Four in five Australian telemedicine users keen to consult online again
Over nine in 10 used telemedicine for the first time during the pandemic.
UN urges stronger COVAX support for APAC
The international organisation is calling for countries with surplus COVID-19 vaccine doses to donate to COVAX.
Subdued economy dampens multinational pharmas’ growth in China
Opportunities for MNCs exist largely in generics and OTC segments.
APAC’s hospitals brace for patient backlogs
Australia faced higher wait times to between 240-365 days for elective surgeries.
India’s hospital industry enjoys high investment demand
Demand for health services is rising in Tier 2 and Tier 3 locations.
Chinese vaccines remain vital in developing nations despite criticisms
Developing nations face inadequate supply as developed nations stockpiled vaccines from top manufacturers.
What will drive India's healthcare investments in coming years?
Although the country has the largest youth population, its number of senior citizens are rising.
Strong state commitment boosts Hong Kong's healthcare sector
The government has allocated 15% of its 2021 budget to healthcare.
Singapore to revamp public health subsidy system
The basis for hospital subsidies will be changed to per capita household income.
Further investment urged for Western China's pharma sector
Human rights issues are seen to have discouraged investment in the region.
APAC's healthcare buyouts doubled to 156 deals in 2020
Deals in the biopharma sector tripled during the year.
Stronger R&D focus in sight for Vietnam's pharmas
Most local pharma firms hold the research on new drugs as their predominant strategy.
Malaysia's private hospitals to play bigger role in COVID-19 battle
The government is integrating public and private hospitals as the healthcare system is at its breaking point.
South Korea's biomedical R&D to flourish on state investment
Companies have also made investments in R&D as they shift away from generic drugs.
Most Read
1. Concord Hospital trials 3D printed skin for burns treatment 2. Will weak enforcement undermine WHO’s pandemic treaty? 3. Abu Dhabi closes four healthcare facilities over fraudulent sick leaves 4. Singapore’s MOH, HDB launch pilot tender for GP clinics at Bartley Beacon 5. Aster Sanad Hospital to expand specialised careResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Healthcare Asia Awards 2025 Winner: Paul Richard Camangian of Our Lady of Lourdes Hospital
Paul Camangian, President & CEO of Our Lady of Lourdes Hospital, highlights how its BIDA Lourdes campaign educates the underserved communities and ensures healthcare access.
Commentary
Strategic brand & design: A smart prescription to drive growth in healthcare